Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lab21 Acquires Business and Assets of Delphic Diagnostics

By LabMedica International staff writers
Posted on 04 Dec 2009
Lab21, (Cambridge, UK) the healthcare diagnostics company, has acquired business and assets of Delphic Diagnostics (London, UK), a specialist laboratory services business with expertise in human immunodeficiency virus (HIV) and hepatitis. More...
The financial details of the acquisition have not been disclosed.

Delphic's business is focused on personalized medicine and companion diagnostics. It has developed a world leading expertise in pharmacology, virology, therapeutic drug monitoring, and specialist clinical trial services to the pharmaceutical industry. It has laboratories in Liverpool and in Kent and partner laboratories across Europe. It has strong quality accreditations, with more than 200 National Health Service (NHS; UK) customers and partnerships with various global pharmaceutical manufacturers.

Graham Mullis, CEO of Lab21, commented, "This acquisition is highly complementary to Lab21's existing business in companion diagnostics, and significantly extends our laboratory capacity and service offering in virology." Mr. Mullis added, "This acquisition is the latest step in our buy-and-build strategy and reinforces our market leadership position in molecular diagnostic services in the UK, specifically in the rapidly growing market for companion diagnostics."

Lab21 supplies tests and services across a broad range including pharmacogenetic tests, gold-standard viral diagnostics, cytochrome P450 genotyping, and viral resistance mapping

Related Links:
Lab21
Delphic Diagnostics


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Portable Electronic Pipette
Mini 96
New
Gel Cards
DG Gel Cards
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.